Mirae Asset Global Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343M Buy
286,254
+13,758
+5% +$14.1M 0.51% 25
2026
Q1
$251M Sell
272,496
-5,252
-2% -$5.32M 0.08% 21
2025
Q4
$298M Buy
277,748
+28,130
+11% +$26.9M 0.83% 17
2025
Q3
$190M Buy
249,618
+15,009
+6% +$11.2M 0.6% 23
2025
Q2
$183M Sell
234,609
-563,318
-71% -$438M 0.64% 21
2025
Q1
$199M Buy
797,927
+515,279
+182% +$429M 0.81% 17
2024
Q4
$220M Sell
282,648
-2,259
-0.8% -$1.87M 0.89% 15
2024
Q3
$250M Buy
284,907
+27,580
+11% +$24.8M 1.11% 14
2024
Q2
$234M Sell
257,327
-76,612
-23% -$61.3M 1.17% 13
2024
Q1
$220M Buy
333,939
+35,703
+12% +$25.4M 0.48% 29
2023
Q4
$174M Sell
298,236
-14,972
-5% -$8.74M 0.35% 49
2023
Q3
$170M Sell
313,208
-15,328
-5% -$7.9M 0.37% 45
2023
Q2
$154M Sell
328,536
-73,225
-18% -$30.7M 0.33% 46
2023
Q1
$138M Buy
401,761
+22,124
+6% +$7.46M 0.32% 53
2022
Q4
$139M Sell
379,637
-74,382
-16% -$26.4M 0.36% 44
2022
Q3
$148M Sell
454,019
-25,394
-5% -$8.05M 0.4% 38
2022
Q2
$155M Sell
479,413
-74,970
-14% -$22.5M 0.4% 37
2022
Q1
$159M Sell
554,383
-97,081
-15% -$25M 0.33% 45
2021
Q4
$180M Buy
651,464
+3,025
+0.5% +$767K 0.39% 39
2021
Q3
$150M Buy
648,439
+163,338
+34% +$40.3M 0.38% 37
2021
Q2
$111M Sell
485,101
-19,383
-4% -$3.89M 0.31% 63
2021
Q1
$94.2M Buy
504,484
+385,362
+324% +$75.4M 0.33% 58
2020
Q4
$20.1M Buy
119,122
+4,161
+4% +$621K 0.07% 317
2020
Q3
$17M Buy
114,961
+46,173
+67% +$7.15M 0.08% 276
2020
Q2
$11.3M Buy
68,788
+1,064
+2% +$163K 0.07% 309
2020
Q1
$9.39M Buy
67,724
+15,911
+31% +$2.19M 0.07% 287
2019
Q4
$6.81M Buy
51,813
+9,210
+22% +$1.07M 0.04% 434
2019
Q3
$4.76M Buy
42,603
+2,818
+7% +$314K 0.03% 476
2019
Q2
$4.41M Sell
39,785
-203,081
-84% -$23.9M 0.03% 487
2019
Q1
$31.5M Buy
242,866
+176,622
+267% +$21.5M 0.23% 100
2018
Q4
$7.67M Sell
66,244
-17,161
-21% -$1.92M 0.07% 287
2018
Q3
$8.95M Buy
83,405
+6,228
+8% +$623K 0.07% 297
2018
Q2
$6.59M Sell
77,177
-19,626
-20% -$1.61M 0.09% 147
2018
Q1
$7.49M Sell
96,803
-882
-0.9% -$71K 0.1% 138
2017
Q4
$8.25M Sell
97,685
-3,192
-3% -$272K 0.11% 127
2017
Q3
$8.63M Buy
100,877
+13,994
+16% +$1.15M 0.16% 114
2017
Q2
$7.15M Sell
86,883
-18,242
-17% -$1.49M 0.12% 119
2017
Q1
$8.84M Buy
105,125
+28,491
+37% +$2.28M 0.17% 105
2016
Q4
$5.64M Buy
76,634
+28,834
+60% +$2.15M 0.13% 129
2016
Q3
$3.84M Buy
47,800
+6,318
+15% +$506K 0.08% 166
2016
Q2
$3.27M Buy
41,482
+12,605
+44% +$949K 0.08% 167
2016
Q1
$2.08M Sell
28,877
-1,006
-3% -$76.1K 0.06% 212
2015
Q4
$2.53M Sell
29,883
-29,627
-50% -$2.46M 0.08% 190
2015
Q3
$4.98M Sell
59,510
-20,275
-25% -$1.71M 0.2% 111
2015
Q2
$6.66M Sell
79,785
-2,721
-3% -$207K 0.21% 94
2015
Q1
$5.99M Buy
82,506
+47,070
+133% +$3.35M 0.2% 86
2014
Q4
$2.44M Buy
35,436
+1,021
+3% +$68.9K 0.09% 148
2014
Q3
$2.23M Buy
34,415
+3,549
+11% +$225K 0.08% 150
2014
Q2
$1.92M Buy
30,866
+776
+3% +$46.3K 0.04% 169
2014
Q1
$1.77M Sell
30,090
-19,642
-39% -$1.1M 0.05% 167
2013
Q4
$2.54M Buy
49,732
+4,041
+9% +$202K 0.11% 118
2013
Q3
$2.3M Buy
45,691
+3,412
+8% +$179K 0.1% 124
2013
Q2
$2.08M Buy
+42,279
New +$2.3M 0.11% 119

Other funds holding LLY

Mirae Asset Global Investments's LLY Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Eli Lilly (LLY) stake by 5% in Q2 2026, buying an estimated $14.1M and bringing the position to 286,254 shares worth $343M. The position accounts for 0.51% of the portfolio, ranked #25.

Mirae Asset Global Investments first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,490 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mirae Asset Global Investments held 286,254 shares of Eli Lilly worth $343M as of Q2 2026.
  • Mirae Asset Global Investments bought 13,758 Eli Lilly shares in Q2 2026, an estimated $14.1M.
  • Eli Lilly made up 0.51% of Mirae Asset Global Investments's portfolio in Q2 2026, its #25 holding.
  • Mirae Asset Global Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.